Investors

Welcome to our Investor Centre

Please click on the Profiles below to see more details on our other clients:

All of the information contained within this website has been compiled from sources believed to be reliable, but no warranty, expressed or implied, is given that the information is complete or accurate or that it is fit for a particular purpose. All such warranties are expressly disclaimed and excluded. Any opinions, recommendations and forecasts referred to are not those of Walbrook PR Limited but are expressly those of third parties, such as investment analysts and financial journalists. Such opinions, recommendations and forecasts may have been superseded and thus may not necessarily be the current opinions, recommendations and forecasts of the relevant analyst/broker. None of the content of this website should be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell, the securities of any listed Company mentioned or featured herein as it is for information only. Any recommendations referred to by third parties do not necessarily imply the suitability of particular securities for individual situations. The value of securities and the income from them may fluctuate. It should be remembered that past performance is not necessarily a guide to future performance. You are strongly advised to seek guidance from a professional investment adviser before entering into any contract to buy or sell any security featured herein. By reading this disclaimer, and ticking the box below, you confirm that you accept and understand its content, and that you shall not hold Walbrook PR Limited, its directors and staff nor any of its subsidiaries or connected companies liable for any loss that you may sustain should you decide to buy or sell any of the mentioned securities.

Tristel plc

Company Profile

Company website
Sector
Health Care Providers (Health Care Services)
Description
Tristel plc is an infection prevention company focused on applying a powerful biocidal chemistry – chlorine dioxide – to the target environmental surface or medical device. The Company has two key areas of focus in the hospital: i) the high-level disinfection of medical devices with its medical device disinfectants and ii) the sporicidal disinfection of environmental surfaces.

Investor Access

26 Feb
Event information
The Company will be announcing its Interim Results on Monday 26 February 2024 for the six months ended on 31 December 2023.
Venue
Online presentation / In-person investor presentation
Time

Online presentation:

It will be held via Investor Meet Company at 11:30am on Monday 26 February 2024.

In-person investor presentation:

It will be held at 85 Gresham Street, London, EC2V 7NQ at 4:30pm on Monday 26 February 2024.
Financial Calendar
 Event  Date
Year End 30 June
Half  Year End 31 December
Preliminary Results* October
Interim Results* February 
AGM* December

* Months based on previous announcements of this kind